Nepal | May 26, 2020

Sorry, there is no content matching your search keywords.

Please try using other keywords.

More Stories from The Himalayan Times

  • World

    Worldwide coronavirus cases cross 5.5 million, death toll tops 345,400

    LONDON: More than 5.5 million people have been reported infected with the novel coronavirus globally and 345,433 have died, a Reuters tally shows. Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019. Here ...

  • Business

    Hotels to provide rooms to quarantine healthcare workers

    Kathmandu, May 23 Tourist standard hotels within the valley have reached agreement with the government to provide rooms to healthcare workers fighting on the frontline against the COVID-19 pandemic. A meeting yesterday between Nepal Tourism Board and Federation of Hotel Entrepreneurs decided t...

  • Kathmandu

    All-party meet held in Baluwatar

    KATHMANDU: An all-party meeting under the convenorship of Prime Minister KP Sharma Oli was held today at the PM's official residence in Baluwatar. According to Prime Minister Oli's Press Advisor, Surya Thapa, the all-party meeting has concluded after nearly three hours of discussion, wherein vari...

  • Opinion

    Reviving economy amidst COVID-19

    The COVID-19 infection and thereby the lockdown has been paralysing the whole world, including Nepal. This epidemic is different from other crises like an earthquake, economic blockade or depression, where there is no lockdown of people, the mobiliser of the world, including the economy. Along with ...

  • Education

    Bodhi Toastmasters Club organises its 75th meeting in Pokhara

    KATHMANDU: Bodhi Toastmasters Club, Kathmandu, organised it's 75th meeting in Pokhara under the theme "Visit Nepal 2020" in collaboration with Pokhara and Gandaki Toastmasters Club. At a time when the country's tourism industry is being marred by the coronavirus outbreak, toastmasters and gue...

  • Lifestyle

    India’s Glenmark to study potential COVID-19 drug combination

    BENGALURU: Glenmark Pharmaceuticals Ltd said on Tuesday it will begin a new clinical trial in India to test a combination of two anti-viral drugs - favipiravir and umifenovir - as a potential COVID-19 treatment. The study will look to enroll 158 hospitalized patients of moderate COVID-19 in In...